Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Zhongda Marine Biotechnology Center of South China Sea is a prominent biotechnology organization based in Guangzhou, China, primarily affiliated with Sun Yat-sen University. The center focuses on the sustainable utilization of marine biological resources, with a specialized emphasis on aquatic animal health and marine-derived therapeutics. It is notably recognized for developing China's first approved aquatic virus vaccine, targeting the White Spot Syndrome Virus in shrimp. Beyond aquaculture, the center engages in the discovery of bioactive marine natural products for use in functional foods and potential pharmaceutical applications. By integrating high-level academic research with industrial production, the center plays a pivotal role in the marine biotech economy of the South China Sea region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Zhongda Marine Biotechnology Center of South China Sea.